By Linda Chiem ( May 13, 2014, 1:04 PM EDT) -- Merck & Co. will sell its ophthalmology assets in Japan and other key markets in Europe and the Asia-Pacific to Japanese drugmaker Santen Pharmaceutical Co. Ltd. for $600 million upfront and additional payments based on sales milestones, the companies announced Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.